Teva's second-quarter sales soar after Barr integration
28 July 2009
Simon Varcoe
Please Login to read the full article.
28 July 2009
Simon Varcoe
simon.varcoe@informa.com
Teva Pharmaceutical Industries' acquisition of Barr Pharmaceuticals drove the Israeli company's net sales up by 20% to $3.4 billion in the second quarter.
Barr contributed to Teva's growth in all of its geographical areas, especially in the US, Russia, Poland, Germany and Croatia.
Pharmaceutical...
Please Login to read the full article.
RELATED CONTENT
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
